Are you Dr. Das?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 37 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St.
Philadelphia, PA 19104Phone+1 215-662-6932Fax+1 215-662-7899
Summary
- Dr. Rituparna Das, MD is an infectious disease specialist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania. She is affiliated with Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, and Philadelphia Veterans Affairs Medical Center.
Education & Training
- Yale-New Haven Medical CenterFellowship, Infectious Disease, 2007 - 2010
- Yale-New Haven Medical CenterResidency, Internal Medicine/Pediatrics, 2003 - 2007
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2003
Certifications & Licensure
- PA State Medical License 2011 - 2024
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- Safety and Immunogenicity of an mRNA-1273 Booster in Children.Vladimir Berthaud, C Buddy Creech, Christina A Rostad, Quito Carr, Liberation de Leon
Clinical Infectious Diseases. 2024-12-17 - 7 citationsHumoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults.Jaya Goswami, Abdullah H Baqui, Pablo A Doreski, Gonzalo Perez Marc, Gilberto Jimenez
The Journal of Infectious Diseases. 2024-11-15 - Safety and immunogenicity of a single-dose omicron-containing COVID-19 vaccination in adolescents: an open-label, single-arm, phase 2/3 trial.Amparo L Figueroa, Dania Torres, Celia Reyes-Acuna, Paul Matherne, Anne Yeakey
The Lancet. Infectious Diseases. 2024-09-24
Press Mentions
- Health News - Study Explains Why Africans May Be More Susceptible to TuberculosisFebruary 10th, 2016